12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Other News

Cardio3 BioSciences cardiovascular news

The Advanced Materials for Cardiac Regeneration (AMCARE) consortium has received €8.7 million ($11.8 million) in funding, including a €6.8 million ($9.2 million) direct EU contribution, through the EU's Framework Programme 7 (FP7), to develop a bioresorbable polymeric valve tube to treat congenital heart defects....

Read the full 198 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >